Falkland Islands Science Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Falkland Islands Science Times.

Press releases published on June 9, 2026

Jun. 9, 2026

Invivyd Announces First Participants Dosed in LIBERTY, a Phase 3 Clinical Trial to Evaluate the Safety and Tolerability of VYD2311 Antibody Versus mRNA COVID Vaccine and to Characterize the Safety and Immunology of Antibody and mRNA Vaccine…

Indeterminate GlobeNewswire

Jun. 9, 2026

FLYR and Res2 Partner to Accelerate Order-Based Delivery

Indeterminate GlobeNewswire

Jun. 9, 2026

MitoRx Therapeutics Strengthens Leadership Team with C-Suite and Board Appointments to Support Next Phase of Growth

Indeterminate GlobeNewswire

Jun. 9, 2026

DBV Technologies Revises Participation in the Goldman Sachs 47th Annual Global Healthcare Conference

Indeterminate GlobeNewswire

Jun. 9, 2026

DBV Technologies révise sa participation à la 47ème conférence annuelle Global Healthcare organisée par Goldman Sachs

Indeterminate GlobeNewswire

Jun. 9, 2026

Antag Therapeutics Elects Keith Leonard as Chairman of its Board of Directors

Indeterminate GlobeNewswire

Jun. 9, 2026

Optimum7 Replatforms Posterazzi from BigCommerce to Shopify with Preview Engine

Indeterminate GlobeNewswire

Jun. 9, 2026

Contentstack Introduces Its Agentic Experience Platform (AXP) With Agent OS and Agent Accelerator to Remove Roadblocks to Enterprise AI ROI and Adoption

Indeterminate GlobeNewswire

Jun. 9, 2026

SailPoint Announces Fiscal First Quarter 2027 Results

Indeterminate GlobeNewswire

Jun. 9, 2026

Revenium Launches AI Insights to Pinpoint and Rank Where Agentic AI Spend is Wasted

Indeterminate GlobeNewswire

Jun. 9, 2026

Atavistik Bio Announces U.S. FDA Clearance of Investigational New Drug Application and Fast Track Designation for ATV-1601 for the Treatment of Hereditary Hemorrhagic Telangiectasia (HHT)

Indeterminate GlobeNewswire

Jun. 9, 2026

NexTel Medical Corp. Announces Groundbreaking, First-of-Its-Kind Exosome Characterization Study with Penn State University

Indeterminate GlobeNewswire

Jun. 9, 2026

Apollo Therapeutics Appoints Timothy P. Walbert as Chairman of the Board

Indeterminate GlobeNewswire

Jun. 9, 2026

Cartesian Therapeutics Announces Strategic Licensing Agreement with WestGene Biopharma to Accelerate the Development of In Vivo CAR-T Platform in Autoimmune Diseases

Indeterminate GlobeNewswire

Jun. 9, 2026

BPGbio Appoints Renowned Neuroscientist Eric J. Nestler, M.D., Ph.D., as Chair of Scientific Advisory Board

Indeterminate GlobeNewswire

Jun. 9, 2026

Kymera Therapeutics Announces First Participant Dosed in Phase 1 Trial of Oral IRAK4 Degrader, KT-485, and Milestone Achievement Under Sanofi Collaboration

Indeterminate GlobeNewswire

Jun. 9, 2026

Synack Supports Majority of Cabinet-Level Federal Departments as New AI Executive Order Raises the Bar on Federal Security

Indeterminate GlobeNewswire

Jun. 9, 2026

Bavarian Nordic modtager ny ordre fra regering på koppe-/mpoxvacciner

Indeterminate GlobeNewswire

Jun. 9, 2026

Bavarian Nordic Secures Additional Government Contract for the Supply of Smallpox/Mpox Vaccine

Indeterminate GlobeNewswire

Jun. 9, 2026

Burning Rock Reports First Quarter 2026 Financial Results

Indeterminate GlobeNewswire